Granberg D - Search Results

1

Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma.

Lindholm DP, Eriksson B, Granberg D. Lindholm DP, et al. Among authors: granberg d. Med Oncol. 2012 Mar;29(1):301-3. doi: 10.1007/s12032-010-9789-4. Epub 2010 Dec 30. Med Oncol. 2012. PMID: 21191667

2

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.

Fjällskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK. Fjällskog ML, et al. Among authors: granberg dp. Cancer. 2001 Sep 1;92(5):1101-7. doi: 10.1002/1097-0142(20010901)92:5<1101::aid-cncr1426>3.0.co;2-v. Cancer. 2001. PMID: 11571721 Clinical Trial.

3

Experience in treatment of metastatic pulmonary carcinoid tumors.

Granberg D, Eriksson B, Wilander E, Grimfjärd P, Fjällskog ML, Oberg K, Skogseid B. Granberg D, et al. Ann Oncol. 2001 Oct;12(10):1383-91. doi: 10.1023/a:1012569909313. Ann Oncol. 2001. PMID: 11762808 Free article.

4

Octreoscan in patients with bronchial carcinoid tumours.

Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Granberg D, et al. Clin Endocrinol (Oxf). 2003 Dec;59(6):793-9. doi: 10.1046/j.1365-2265.2003.01931.x. Clin Endocrinol (Oxf). 2003. PMID: 14974924

5

Neuroendocrine tumours.

Granberg D, Oberg K. Granberg D, et al. Cancer Chemother Biol Response Modif. 2005;22:471-83. Cancer Chemother Biol Response Modif. 2005. PMID: 16110625 Review. No abstract available.

6

Gastrin-releasing-peptide in neuroendorine tumours.

Granberg D, Skogseid B, Welin S, Orlefors H, Oberg K, Wilander E. Granberg D, et al. Acta Oncol. 2006;45(1):23-7. doi: 10.1080/02841860500367434. Acta Oncol. 2006. PMID: 16464792

7

Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines.

Larsson DE, Lövborg H, Rickardson L, Larsson R, Oberg K, Granberg D. Larsson DE, et al. Among authors: granberg d. Anticancer Res. 2006 Nov-Dec;26(6B):4125-9. Anticancer Res. 2006. PMID: 17201123 Free article.

8

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors.

Granberg D, Eriksson LG, Welin S, Kindmark H, Janson ET, Skogseid B, Oberg K, Eriksson B, Nyman R. Granberg D, et al. Acta Radiol. 2007 Mar;48(2):180-5. doi: 10.1080/02841850601080440. Acta Radiol. 2007. PMID: 17354139

9

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Orlefors H, Sigurd M, Oberg K, Eriksson B, Skogseid B. Ekeblad S, et al. Among authors: granberg d. Clin Cancer Res. 2007 May 15;13(10):2986-91. doi: 10.1158/1078-0432.CCR-06-2053. Clin Cancer Res. 2007. PMID: 17505000

10

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Kindmark H, Sundin A, Granberg D, Dunder K, Skogseid B, Janson ET, Welin S, Oberg K, Eriksson B. Kindmark H, et al. Among authors: granberg d. Med Oncol. 2007;24(3):330-7. doi: 10.1007/s12032-007-0011-2. Med Oncol. 2007. PMID: 17873310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results